Investor s Fiduciary Advisor Network LLC Makes New $4.03 Million Investment in Merck KGaA $MKGAF

Posted by George Bondi on Aug 24th, 2026

Investor s Fiduciary Advisor Network LLC acquired a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The firm acquired 31,358 shares of the company’s stock, valued at approximately $4,029,000. Merck KGaA accounts for 1.4% of Investor s Fiduciary Advisor Network LLC’s investment portfolio, making the stock its 21st biggest holding.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Frazier Financial Advisors LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter worth about $25,000. Rakuten Securities Inc. acquired a new stake in Merck KGaA during the 2nd quarter worth approximately $27,000. Solstein Capital LLC purchased a new position in Merck KGaA in the second quarter valued at approximately $33,000. Burk Holdings LLC purchased a new position in Merck KGaA in the second quarter valued at approximately $39,000. Finally, Bard Associates Inc. acquired a new position in Merck KGaA during the second quarter valued at approximately $60,000. 0.10% of the stock is owned by institutional investors and hedge funds.

Merck KGaA Price Performance

MKGAF opened at $163.21 on Monday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company has a 50 day moving average of $162.62 and a two-hundred day moving average of $148.44. The company has a market cap of $21.09 billion, a P/E ratio of 24.92 and a beta of 0.96.

Merck KGaA Company Profile

(Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.